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Objective: This study was undertaken to assess the impact of increasing patient complexity and health care cost
on coronary artery bypass grafting quality and cost-effectiveness in the United States over an 18-year period.
Methods: A retrospective study was carried out utilizing the Nationwide Inpatient Sample to track the character-
istics and outcomes of 5,549,700 patients having isolated coronary artery bypass grafting in the United States
from 1988 to 2005. Expected mortality, risk-adjusted mortality, and hospital charges were tracked over this pe-
riod.
Results: The prevalence of congestive heart failure, pulmonary disease, diabetes, and acute myocardial infarction
increased significantly over the study period. Expected mortality increased from 2.57% to 3.66%, reflecting the
increasing patient comorbidity burden (P< .0001). Despite this, coronary artery bypass grafting outcomes im-
proved, leading to a decrease in risk-adjusted mortality from 6.20% to 2.12% (P< .0001). Furthermore,
when hospital charges were corrected for medical care inflation, hospital charges declined significantly, from
$26,210 in 1988 to $19,196 in 2005 (1988 dollars, P< .0001).
Conclusions: Coronary artery bypass grafting surgery is being performed on an increasingly complex, high-risk
patient population in the United States. Despite this challenge, risk-adjusted operative mortality has progressively
declined. Moreover, hospital charges for coronary artery bypass grafting in relation to other medical care services
have been reduced. These findings reflect improved quality and cost-effectiveness of coronary artery bypass graft-
ing in the United States. Ongoing efforts directed at quality improvement should address the risks associated with
comorbidities that increasingly accompany the diagnosis of coronary artery disease in patients having coronary
artery bypass grafting.Coronary artery bypass grafting (CABG) has been routinely
performed for the treatment of obstructive coronary artery
disease (CAD) for the past 4 decades.1-3 Over this period,
the patient population having CABG has changed signifi-
cantly due to advancements in medical therapy and percuta-
neous techniques. Furthermore, CABG surgery has become
recognized as preferred treatment for patients in high-risk
subgroups, including those with more extensive CAD and
diabetes.4-6 Although the patient population having CABG
has become increasingly complex, cardiovascular surgery
has become safer because of advances in surgical techniques
and the related disciplines of anesthesia, perfusion, and crit-
ical care.7-12 Changes in the patient population and advances
in the perioperative care of patients having CABG have the
potential to impact both the clinical and economic outcomes
of CABG surgery.
This study was undertaken to assess the impact of these
changes on CABG quality and cost-effectiveness in the
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doi:10.1016/j.jtcvs.2008.09.053The Journal of Thoracic andUnited States over an 18-year period. A retrospective study
was carried out utilizing the Nationwide Inpatient Sample
(NIS), a project of the Agency for Healthcare Research
and Quality. This database is the largest all-payer inpatient
care database publicly available in the United States and
allows analysis of national trends in health care utilization,
outcomes, and charges. Given the current economic chal-
lenges faced by the health care system, studies of treat-
ments that measure quality as well as cost-effectiveness
will be important to assess the efficiency of health care de-
livery.
MATERIALS AND METHODS
Data were selected from the NIS combining the years 1988 to 2005. The
NIS is a stratified randomized 20% sample of patient discharge abstracts
from nonfederal hospitals.13 In combining the multiple years of NIS data,
the revised statistical weights for comparisons across time were used.
Cases were included in the analysis if they had a recorded CABG proce-
dure, International Classification of Diseases, 9th Revision, Clinical Modi-
fication (ICD-9-CM) procedure code 36.1 and all subcodes. Cases were
excluded if they had an aortic, mitral, or tricuspid valve replacement
(35.21 to 35.24, 35.27, 35.28), excision of aneurysm or other lesion
(37.32, 37.33), partial ventriculectomy (37.35), heart revascularization
(36.3 and all subcodes), heart transplant (37.5 and all subcodes), thoracic
vessel resection (38.45), or endarterectomy of carotid artery or jugular
vein (38.12). Patients having these procedures were excluded to yield an
isolated CABG population.
The primary end points were in-hospital mortality and total charges. To-
tal charges generally do not include professional fees and noncoveredCardiovascular Surgery c Volume 137, Number 1 65
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CABG ¼ coronary artery bypass grafting
CAD ¼ coronary artery disease
ICD-9-CM ¼ International Classification of
Diseases, 9th Revision, Clinical
Modification
NIS ¼ Nationwide Inpatient Sample
charges. Patient comorbidities were defined based on diagnosis codes pres-
ent in the discharge abstract as described previously.14
Expected and risk-adjusted mortalities were determined from a logistic
regression model of in-hospital mortality adjusting for age, sex, comorbid-
ities (congestive heart failure, chronic pulmonary disease, diabetes [compli-
cated or uncomplicated], peripheral vascular disorders, liver disease, renal
failure, and cerebral vascular disease [defined as ICD-9-CMdiagnosis codes
433 and all subcodes and 437.0]), preoperative conditions (primary diagno-
sis of myocardial infarction, cardiac catheterization on the same day as
CABG, previous CABG [ICD-9-CM code V45.81], and admission status
[elective versus nonelective]). Risk-adjustment variables were selected
based on available variables that have previously been found to be associ-
ated with mortality in CABG and have been used in previous studies using
administrative data.15,16 From this model, a predicted mortality for every pa-
tient was determined. From these individual predicted mortalities, the ex-
pected mortality for each year was determined and the ratio of observed
to expected mortality was multiplied by the overall mortality to give the ex-
pected mortality rate for each year.
Charge data were adjusted for inflation using the Consumer Price Index
published by the US Department of Labor, Bureau of Labor Statistics. The
specific series used were US city average all items (series CUUS0000SA0)
and US city average medical care services (series CUUS0000SAM2). The
medical care services series includes professional services, hospital and re-
lated services, and health insurance. Charge data were normalized to 1988
dollars.
This study was approved by the Institutional Review Board at Oregon
Health & Science University. Individual consent was waived.
RESULTS
In total, 1,066,374 cases met the study criteria, represent-
ing a national estimate of 5,549,700 isolated CABG cases
performed over the 18-year period. Patient demographics,
comorbidities, the presence of myocardial infarction as a pri-
mary diagnosis, the use of cardiac catheterization on the
same day as the CABG procedure, and the in-hospital mor-
tality and total charges are presented in Table 1. The varia-
tions of these across time are also shown with the 18-year
time period being broken down into 6 3-year groups.
The incidence of all comorbidities increased significantly
over the study period. The magnitude of this increase was
also notable, with most comorbid conditions at least dou-
bling in frequency over the study period. The incidence of
diabetes mellitus increased from 16.66% in the first 3-year
group to 33.85% in the most recent 3-year group. The diag-
nosis of myocardial infarction also increased over the study
period, suggesting higher acuity of patients having CABG
over time. Previous CABG, in contrast, declined from
3.49% to 1.24% over this same time period. Despite the in-66 The Journal of Thoracic and Cardiovascular Surgcreases in comorbidities and higher acuity of patients having
surgery, observed in-hospital mortality declined progres-
sively from 4.81% to 2.34%.
As shown in Figure 1, expected mortality progressively
increased over the 18-year interval from 2.57% to 3.66%
(solid line, P< .0001). This reflects the increasing preva-
lence of patient comorbidities known to influence risk at
the time of CABG.
Although expected mortality progressively increased over
the study period, risk-adjusted mortality decreased over the
same time course (Figure 1, dashed line). This change was
more substantial than that seen in expected mortality, with
reduction in risk-adjusted mortality from 6.20% in 1988
to 2.12% in 2005 (P< .0001). The improvement seen in
risk-adjusted mortality occurred steadily over the study pe-
riod, without dramatic step-offs. This improvement contin-
ued through the most recent years of the study period.
From the year 2000 until 2005, adjusted mortality decreased
from 2.32% to 2.12% (P< .0001).
Given the increase in patient comorbidities seen in the
CABG patient population, there was interest to determine
how this may have impacted the economic outcomes of
CABG.Hospital charges for CABGadmissionswere tracked
over the study period and are depicted in Figure 2.When cor-
rected for all-item inflation, hospital charges associated with
CABG increased from $26,410 in 1988 to $46,734 in 2005
(1988 dollars, solid line, P< .0001). Hospital charges were
relatively stable over the years 1994 to 1999, but increased
from $30,813 in 1999 to $46,734 in 2005.
The cost of health care delivery has generally increased
more quickly than the rate of all-item inflation.17-20 To cor-
rect for this accelerated rise in the cost of health care, hospi-
tal charges for CABG were adjusted for medical inflation
(Figure 2, dashed line). When this was done, hospital
charges associated with CABG decreased significantly
over the study period, from $26,210 in 1988 to $19,196 in
2005 (1988 dollars, P< .0001). The decline in hospital
charges adjusted for medical inflation occurred in the years
1988 to 1999. From the year 2000 to 2005, hospital charges
actually rose, from $16,800 to $19,196 (P< .0001).
DISCUSSION
This study was undertaken to assess changes in the pa-
tient population having CABG in the United States from
1988 to 2005 and how these changes may have impacted
clinical and economic outcomes of CABG. The prevalence
of patient comorbidities known to impact operative mortal-
ity increased over the study period, leading to increased
expected mortality. Despite this increase in patient com-
plexity, risk-adjusted mortality decreased substantially.
Moreover, hospital charges for CABG in relation to other
medical care services have been reduced. These findings
reflect improved quality and cost-effectiveness of CABG
in the United States.ery c January 2009
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DTABLE 1. Demographics, comorbidities, condition, and outcomes of patients having coronary artery bypass grafting (CABG) in the United States
from 1988 to 2005
All years 1988–1990 1991–1993 1994–1996 1997–1999 2000–2002 2003–2005
n (national estimate) 5,549,700 745,295 905,194 1,029,994 1,055,483 1,022,954 790,780
Demographics
Age (y)* 65.2 (24.0) 64.6 (24.3) 65.2 (23.8) 65.4 (23.7) 65.6 (24.0) 65.3 (24.1) 65.2 (23.9)
Sex (%)
Male 71.51 73.71 72.45 71.21 70.13 70.57 71.79
Female 28.49 26.29 27.55 28.79 29.87 29.43 28.21
Comorbidities (%)
Congestive heart failure 0.68 0.13 0.49 0.76 0.70 0.96 0.93
Chronic pulmonary disease 15.27 8.66 11.60 14.46 16.53 18.60 20.78
Diabetes mellitus 26.30 16.66 20.07 25.11 28.77 31.65 33.85
Peripheral vascular
disorders
7.70 4.46 5.11 7.48 8.53 9.34 10.73
Liver disease 0.32 0.10 0.14 0.23 0.30 0.47 0.67
Renal failure 2.83 1.22 1.96 2.30 2.77 3.65 5.05
Cerebral vascular disease 3.11 2.34 3.04 2.97 3.36 3.15 3.74
Preoperative condition (%)
Primary diagnosis
of myocardial infarction
19.24 10.64 16.47 19.78 21.14 22.15 23.54
Cardiac catheterization
on the same day as CABG
29.12 18.47 30.28 39.53 33.16 23.64 25.93
Previous CABG 2.67 3.49 2.92 3.19 2.96 2.12 1.24
Nonelective admission 58.47 59.50 63.05 61.75 59.11 53.66 53.96
Outcomes
Died during
hospitalization (%)
3.32 4.64 3.83 3.32 3.08 2.78 2.48
Total charges
(dollars)y
43732 (31179–
64423)
30191 (22888–
41604)
38802 (29539–
53769)
39648 (29265–
54728)
42244 (31463–
58845)
51451 (37540–
75553)
70827 (51651–
105685)
*Mean (standard deviation); ymedian (interquartile range). All variables statistically significant at P< .001.The decrease in mortality was progressive over the entire
study period and is likely related to multiple incremental ad-
vances in surgery practice and the related fields of anesthe-
siology and critical care as opposed to singular advances.
In addition to technical advances, the introduction of quality
improvement programs have had a profound effect on car-
diac surgery outcomes.11,21-23 Cardiothoracic surgeons
have been leaders in this area and continue to champion vol-
untary clinical databases for the purpose of both regional and
national efforts in quality improvement.
The improvement in risk-adjusted mortality was achieved
with decreased hospital charges for CABG after adjustment
for medical inflation. The improved safety of CABG is likely
to have led to some of this decrease in hospital charges, as
avoidance of complications is associated with lower proce-
dural cost.24,25 In addition, numerous practice pathways
were implemented into cardiovascular surgery practice dur-
ing the study period, leading to improved efficiency and
decreased cost.26 An example of improved safety and effi-
ciency is seen in the reduction in length of stay associated
with CABG, which decreased from 11 to 8 days over the
study period (P< 0.0001, data not shown). A concerning
finding of our study is that the recent period from 2000 toThe Journal of Thoracic and2005 saw increases in hospital charges after adjustment for
medical inflation, possibly reflecting the higher cost of
care for an increasingly complex patient population.
This study utilized the NIS to track trends in CABG prac-
tice in the United States. Advantages of this database include
its national scope, the relatively long period for which data
FIGURE 1. Expected and risk adjustedmortality of coronary artery bypass
grafting (CABG) in the United States from 1988 to 2005.Cardiovascular Surgery c Volume 137, Number 1 67
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Dare available, and the availability of charge information on
all patients, regardless of payer. The NIS is not a clinical da-
tabase, and its data fields were not designed to risk model
CABG outcomes. Inpatient stay data are derived from infor-
mation typically available from discharge abstracts. The NIS
is therefore subject to coding errors and changes in reporting
patterns that may have occurred over time.
To test the accuracy for prediction of the logistic risk
model, a c-index was calculated and found to be 0.71, which
was reassuring.15 This value, which is a traditional approach
to assess model performance, fell in the same range as that
reported for risk models using clinical databases, including
the Society of Thoracic Surgeons National Adult Cardiac
Surgery Database.
Another weakness of the study was that although the
charge data are useful to track trends in CABG resource
utilization, they do not provide an assessment of the cost–
utility relationship associated with CABG, as charge data
lack an estimate of CABG benefit such as quality-adjusted
life-years. Furthermore, hospital charges only reflect part
of the total cost of CABG to the health care system and do
not account for the total cost of recovery, including inpatient
rehabilitation.
Despite these limitations, this study does demonstrate the
increasing complexity of the patient population having
CABG in the United States. The continuous pursuit of in-
creased safety and efficiency in cardiovascular surgery has
led to improved clinical outcomes and greater cost-effective-
ness. Ongoing efforts directed at quality improvement
should address the risks associated with the comorbidities
that increasingly accompany the diagnosis of coronary ar-
tery disease in our patients. Cost containment will continue
to be a challenge as the CABG population continues to be-
come more complex.
FIGURE 2. Hospital charges for coronary artery bypass grafting (CABG)
in the United States from 1988 to 2005. Expressed in 1988 dollars.68 The Journal of Thoracic and Cardiovascular SurReferences
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